missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Neratinib
Description
Neratinib is a potent, irreversible inhibitor of HER-2/ErbB2 receptor tyrosine kinase and EGFR kinase (IC50 = 59 nM and 92 nM, respectively). Neratinib reduces receptor autophosphorylation and proliferation of EGFR-dependent cancer cells, blocks cell-cycle progression and inhibits HER-2 signaling pathways. Neratinib suppresses proliferation of gefitinib -resistant non-small cell lung cancer cells expressing mutant EGFR. Also inhibits MST1 (IC50 = 37.7 nM). Orally bioavailable.
Spécifications
Spécifications
| Chemical Name or Material | (2 E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide |
| CAS | 698387-09-6 |
| Quantity | 50 mg |
| Target | EGF Receptor Inhibitors |
| Molecular Formula | C30H29ClN6O3 |
| Purity | 0.98 |